Objective: To assess maternal postpartum and neonatal outcomes associated with previous method of delivery.
Introduction
The number of cesarean (CS) deliveries continues to increase for a myriad of medical and non-medical reasons. This rise has been noted in both primary and repeat CSs. The total CS delivery rate in the United States has steadily climbed over the past 50 years from <5 per cent (1960s) to an all-time high of 31.8% (2007) . The exception to this steady rise occurred during the 1990s when multiple strategies to lower the rate were fueled by the popularity of vaginal birth after cesarean (VBAC) and various efforts to reduce primary CS sections. By 1997, rates of VBAC peaked at 28% only to dramatically plummet in popularity thereafter to where, by 2006, the rate fell to 7.6%. 1 The CS section rate began rising once again as did the concerns over uterine rupture, strict guidelines for in-house coverage for safe performance and generalized concerns over the long-term effects on women for vaginal deliveries such as increased pelvic relaxation. Concurrent with the rise in both primary and repeat CSs, reports describing associated maternal, fetal and neonatal morbidities and mortalities after CS section have been published. [2] [3] [4] [5] A consensus committee opinion stated medical decision making should be guided by the ethical principles of respect for patient autonomy, beneficence and nonmaleficence. In the opinion, the committee acknowledged that the problem with weighing these factors comes from the limited data available regarding future pregnancy risks of previous CS versus vaginal delivery (VD). 6 Clearly, accurate risk/benefit information is needed to adequately counsel the increasing number of women requesting elective primary CSs and to educate practitioners in understanding the future reproductive implications after a CS. Most previous analyses have focused on comparisons between elective repeat CS and trial of labor (TOL). [7] [8] [9] However, to appreciate the impact of a CS on subsequent pregnancies, it is necessary to compare the outcomes between pregnancies in multiparous patients with a prior CS and those with only prior vaginal birth.
The purpose of this study is to compare postpartum outcomes in patients with a prior CS delivery with those in patients with a prior VD to assess the risks and benefits of CS delivery on subsequent pregnancies. A better understanding of this comparison will aid in proper counseling of patients with respect to what efforts will be taken to proceed with or avoid CS delivery.
Methods
This study was a retrospective analysis of a prospectively collected quality assurance database in deliveries coded by the route of prior delivery. Approval was obtained by the Institutional Review Board for the MemorialCare Medical Centers located in Long Beach, California. Information on all mothers and infants delivered from July 2002 to December 2003 of term (>36 weeks) singleton deliveries in the four hospitals of the MemorialCare system was collected. Maternal data were obtained from a database dedicated to perinatal outcomes. Neonatal data were obtained from a quality improvement database derived from discharge and procedure codes. Data are routinely reviewed for accuracy and completeness by dedicated nurses who review entered data. In addition, the software has built in alerts triggered at the time of data entry to warn of inaccurate or erroneous results being recorded. Lastly, before submitting monthly quality reports, a data-checking program evaluates the data set. For study purposes, separate data tables were constructed and anonymous identification codes were used for data analysis.
Patients were divided into the following: (i) multiparous with prior VD (VD control) and (ii) multiparous with prior CS delivery. For our secondary analysis the latter group was subdivided by TOL and no trial of labor (No TOL) in the subsequent pregnancy. Each group was compared with the prior VD group (VD control).
The rates of maternal postpartum and neonatal complications were compared. Maternal complications included blood transfusion (Blood Tx), admission to the intensive care unit (ICU), serious postpartum infections requiring aminoglycoside administration, thromboembolic events (DVT) and hospital readmission. Neonatal rates of infections, seizures, encephalopathy, surfactant use, ventilatory support, prolonged hospitalization and death were compared.
Results were compared by w 2 -analysis for categorical variables and Student's t-test for continuous variables. Rates and relative risks were determined with a 95% confidence interval (CI). Statistical significance was determined at P<0.05. Statistical analysis was carried out using Pepi Version 4.0 (Software used at Women's Hospital, Saddleback Memorial Medical Center, Laguna Hills, CA, USA).
Results
During the study period, there were 17 406 singleton births. The study population is described in Figure 1 . Twelve patients were not included in the analysis due to improper coding.
The TOL rate in women with a prior CS was 20.8%, of these 80.0% succeeded in having a VD for an overall VBAC rate of 16.1%. The mean gestational age at delivery did not differ between those with a prior vaginal or CS (38.8 and 38.3 weeks, respectively). The mean parity of those with prior vaginal or CS delivery were the same (1.8 pregnancies). The racial distribution was also similar among the groups ( Figure 2 ).
With respect to clinical outcomes, maternal complications were noted in the CS group. Patients having a prior CS had more than a 2.5-fold risk of requiring blood transfusion, nearly a fourfold higher risk of admission to the ICU and were 1.5 times more likely to be readmitted to the hospital than those with a prior VD (Table 1) . For our secondary analysis, the prior CS group was divided by whether they had a TOL. The subdivided groups were separately compared with control patients who had prior vaginal births ( Table 2) . The prior CS patients with a TOL had increased administration of aminoglycosides than those with prior vaginal births. However, the prior CS with subsequent TOL patients did not differ in their requirement for blood transfusion, intensive care admission or hospital readmission compared with those with a prior VD. Conversely, prior CS patients without a TOL (CS-No TOL) had an increased risk of blood transfusion, intensive care admission and hospital readmission. It was this subgroup that accounted for the morbidities in the prior CS group.
With respect to neonatal outcomes in our primary analysis, infants born to mothers with a history of a prior CS birth were more likely to require ventilatory support and have prolonged hospitalization for more than 7 days. There was no difference in the frequency of sepsis work ups, seizures, encephalopathy, surfactant administration, ventilatory support, lumbar puncture or mortality (Table 3) .
Infant outcomes were also examined by subgrouping on the basis of presence of a TOL (Table 4) . Infants born to mothers with a prior CS who underwent a TOL were less likely to have prolonged hospitalization for more than 7 days than those born to mothers with a prior VD, and did not have an increased need for ventilatory support. In contrast, infants of mothers with a prior CS without TOL in subsequent pregnancy were more likely to remain in the hospital for more than 7 days and more likely to require ventilatory support than those with a prior VD.
To explain the differences in maternal and neonatal outcomes between those women with and without a history of prior CS birth, we evaluated the outcomes of these women based on the medical complications of diabetes and hypertension. There were a small number of patients with the medical complications of diabetes and hypertension in patients with and without a history of CS birth and did not seem to explain the differences between the groups. Only a few outcome complications were noted in the small number (N ¼ 231) of type I and II diabetic patients and did not change the overall results when patients with a prior CS were compared with those with prior VD. The frequency of complications was similar for hypertensive patients with and without a prior CS, except for blood transfusion and ICU admission. Women with a prior CS were at increased risk of blood transfusion and ICU admission independent of the presence of hypertension. In patients with a prior CS, compared with prior VD, the relative risk of transfusion was similar in patients with hypertension (risk ratio (RR) 2.8, CI 1.21 to 6.60, P<0.05) and without hypertension (RR 2.3, CI 1.51 to 3.47, P<0.001). Similarly, the risk of ICU admission was persistently increased in patients with prior CS with hypertension (RR 2.83, CI 1.21 to 6.60 P<0.05) and without hypertension (RR 3.54, Risk of prior cesarean delivery in future pregnancies AM Galyean et al CI 2.10 to 5.97, P<0.001). These comorbidities were equally distributed among the groups.
Discussion
There are well-established data to guide physicians who are counseling patients regarding the immediate post-operative complications after a CS delivery. 10, 11 However, there are limited data available regarding the effect of a prior CS on maternal and neonatal outcomes in future pregnancies. The majority of the literature on future reproductive outcome compares women with prior CSs who undergo TOL with those who undergo elective repeat CS. However, to understand the risk of primary CS delivery, a more appropriate comparison of future complications uses a standard control group who has not had the prior intervention of CS delivery. Rageth et al.
12 compared patients with a prior CS with those without and found an increased risk in maternal and neonatal peripartum complications, including ectopic pregnancy, hysterectomy, febrile episodes and thromboembolic events. This study also compared patients with a prior CS who underwent a labor trial with those with an elective CS in an effort to identify criteria to choose subsequent mode of delivery. 12 However, the available literature is lacking a comparison of patients with a prior CS subdivided by TOL and No TOL and comparing each group to the control group (prior VD).
Patients undergoing a CS preceded by labor have been shown to be at higher risk for endometritis than those who did not labor. van Haam 3 reported a higher risk in postpartum fever in patients undergoing CS after labor compared with those who did not labor (27.9 versus 15.7% P<0.001), but did not show a significant difference in post-operative endometritis. Both Wen 7 and McMahon 9 found a decreased risk of postpartum infection/fever with the TOL group, however, this protective influence was lost if the patient's labor was unsuccessful and resulted in a CS delivery. In our study, the prior CS patients with a subsequent TOL had increased administration of aminoglycosides (our indicator for serious postpartum infection) than those with a prior VD. This group consisted of all women that had a labor trial, including those that were unsuccessful and delivered by repeat CS.
Our findings of increased rate of blood transfusion in patients with a CS is similar to that of Reyal et al., 13 who found CS delivery to be a significant predictor of hemorrhage requiring blood transfusion. In our secondary analysis, the prior CS delivery without TOL group had a significantly increased likelihood of requiring blood transfusion. This differs from the findings reported by the MFM network, 14 but is similar to those reported in a comprehensive meta-analysis by Mozurkewich and Hutton. 15 With the current CS rate exceeding 31%, more than one million American women may be placed at risk every year for requiring a blood transfusion in their next pregnancy, along with the associated risks of transfusion reactions and infectious morbidity.
From a social aspect, the future impact that has not been addressed when considering pregnancy outcomes with a prior CS is the effect on bonding and attachment between the motherinfant dyad. The increase in maternal admissions to the ICU, maternal readmission to the hospital, prolonged neonatal length of stay and neonatal ventilatory support in patients with a prior CS who have a subsequent repeat CS without TOL each have the potential to impose a barrier to early and frequent maternalinfant interaction. The comprehensive studies of Bowlby 16 correlated infant behavior with proximity of the mother. This alteration in maternal-infant bonding is well studied in the premature infant but has not been studied in term infants in regard to postpartum outcomes that preclude maternal-infant bonding. Lydon-Rochelle et al.
10 found significant risk of maternal hospital readmission in patients after a CS birth (RR 1.8, 95% CI 1.6 to 1.9). Our data confirm this increased risk persists in future pregnancies as well. Being readmitted has the potential to negatively affect mother-impact bonding, in addition to the medical consequences.
The initial proponents of elective primary CS at term based their argument on the premise of preventing birth injury to infants. The subsequent data have not supported a clear benefit from pre-labor CS delivery. However, such benefits must be weighted against the pulmonary problems in the newborn. 4, 17, 18 Levine et al. 4 showed that term infants delivered by elective CS delivery have a significant increased risk of transient tachypnea in the newborn and pulmonary hypertension when compared with those born vaginally. To evaluate the role of labor in lung fluid excretion we used neonatal ventilatory support as an indicator of significant pulmonary disease. There was a statistically significant difference in neonatal ventilator use between all patients with a previous CS compared with those with previous VD. Subsequent analysis showed a protective effect with a TOL compared with no trial in requirement for ventilatory support. These findings agree with those by Loebel et al. who found a twofold increase in neonatal respiratory complications in patients undergoing an elective repeat CS compared with those having a TOL, and a threefold increase compared with those having successful VBAC. 8 Our data support these concerns as evidenced by the repeat CS group without TOL had increased ventilatory support and protracted hospital stay.
Unexpectedly, the neonates of mothers with previous CSs who labored were less likely to have prolonged hospitalization than those with prior VD. By our study design we cannot exclude that this may be a reflection of selecting low-risk patients for a TOL. The decision regarding which patients are offered a VBAC has become one of the precautionary measures. For the most part, only patients otherwise considered as low risk are afforded the option of a TOL. Confirming this perception, we found the TOL patients to have minimal medical risk factors and their neonates were discharged sooner.
Patient-choice CS initially received attention in 1985 19 and has recently been a subject of controversy in numerous magazine articles, medical journals, and official opinions of the American College of Obstetrics and Gynecology. 6,19 -23 Contributing to this conflict is the paucity of data describing the effect of a primary CS on maternal and neonatal outcomes in future pregnancies. 24 The current medicolegal and obstetrical climate is encouraging more elective CSs and fewer VBACs with little data to adequately and appropriately counsel patients seeking guidance. Perhaps more important and clinically relevant are the CS deliveries that may be avoided. Examples may include improved training and usage of operative vaginal deliveries, external cephalic versions and physician tolerance of labor variations, such as extending the diagnosis of active-phase arrest from 2 to 4 h. 25 Focusing attention on the means to prevent a primary CS in laboring patients could have significant impact on maternal and neonatal outcome. We have shown patients with a prior CS to be at increased risk for several important maternal postpartum and neonatal outcomes that must be considered.
The strengths of our study are the diverse study population, the large sample size and comparison with a novel control group. Potential limitations of our study include its retrospective study design and the potential for coding error within the database. In addition, there may be potential confounders, which we did not identify or control for. However, we did examine race/ethnicity and gestational age and found no differences between the groups. In summary, compared with patients with a previous VD, patients with a prior CS delivery have a significant increase in various maternal postpartum and neonatal morbidities in future pregnancies. The risks exist whether they undergo a subsequent TOL or elective repeat CS. The effects of these findings may be magnified in patients with multiple CSs, although our data did not address this specifically. Our findings further highlight the low-risk nature of delivery in the multiparous woman with prior VD who is much less likely to have complications or extensive surgery. They also confirm the importance of identifying a clear indication for primary CS deliveries in all women, and avoiding perfunctory decisions and 'soft' indications for CS. The risk/benefit analysis of CS delivery should take these findings into account, particularly when counseling a patient for an elective primary CS who is potentially being deprived of the lower risks she and her babies would experience in subsequent pregnancies if she successfully delivers vaginally on the initial pregnancy.
